Pieris Pharmaceuticals Appoints Allan Reine, M.D., as Chief Financial Officer
Go back to Pieris Pharmaceuticals Appoints Allan Reine, M.D., as Chief Financial Officer| (NASDAQ: PIRS) | Delayed: 13.60 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.60 | 52 Week High | $3.08 | |||
| Open | $13.60 | 52 Week Low | $1.29 | |||
| Day High | $13.60 | P/E | N/A | |||
| Day Low | $13.60 | EPS | $0.00 | |||
| Volume | 500 | |||||
